Modeling the spread of polio in an IPV-vaccinated population: Lessons learned from the 2013 silent outbreak in southern Israel

BMC Medicine

Volumn 14, Issue 1, 2016, Pages

  Yaari, Rami ^a,b   Kaliner, Ehud ^c   Grotto, Itamar ^c,d   Katriel, Guy ^e   Moran Gilad, Jacob ^c,d   Sofer, Danit ^c   Mendelson, Ella ^b,c   Miller, Elizabeth ^b,f   Huppert, Amit ^a,b  

^a GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c MINISTRY OF HEALTH   (Israel)

^d BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^e ORT BRAUDE COLLEGE   (Israel)

^f PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Inactivated polio vaccine; Model fitting; Oral polio vaccine; Polio; Transmission model; Vaccination strategies

Indexed keywords

POLIOMYELITIS VACCINE; ORAL POLIOMYELITIS VACCINE;

ARTICLE; BEDOUIN; DISEASE ERADICATION; EARLY DIAGNOSIS; EPIDEMIC; HUMAN; INCIDENCE; ISRAEL; POLIOMYELITIS; POLIOMYELITIS VIRUS; SEASONAL VARIATION; VIRUS TRANSMISSION; ARAB; CHILD; DISEASE OUTBREAKS; INFANT; PRESCHOOL CHILD; PROCEDURES; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; TRANSMISSION; VACCINATION;

ARABS; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; HUMANS; INFANT; ISRAEL; MODELS, STATISTICAL; POLIOMYELITIS; POLIOVIRUS VACCINE, INACTIVATED; POLIOVIRUS VACCINE, ORAL; VACCINATION;

EID: 84978066578     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/s12916-016-0637-z     Document Type: Article

References (37)

1. IMB. Independent Monitoring Board of the Global Polio Eradication Initiative - Twelfth Report. 2015.
2. Anis E, Kopel E, Singer S, Kaliner E, Moerman L, et al. Insidious reintroduction of wild poliovirus into Israel, 2013. Eurosurveillance. 2013;18:20586. doi: 10.2807/1560-7917.ES2013.18.38.20586.
3. Kaliner E, Moran-Gilad J, Grotto I, Somekh E, Kopel E, Gdalevich M, et al. Silent reintroduction of wild-type poliovirus to Israel, 2013-risk communication challenges in an argumentative atmosphere. Eurosurveillance. 2014;19:20703.
4. Manor Y, Shulman L, Kaliner E. Intensified environmental surveillance supporting the response to wild poliovirus type 1 silent circulation in Israel, 2013. Eurosurveillance. 2014;19:20708.
5. Shulman L, Gavrilin E, Jorba J, Martin J, Burns C, et al. Molecular epidemiology of silent introduction and sustained transmission of wild poliovirus type 1, Israel, 2013. Eurosurveillance. 2014;19:20709. doi: 10.2807/1560-7917.ES2014.19.7.20709.
6. Moran-Gilad J, Mendelson E, Burns CC, Bassal R, Gdalevich M, et al. Field study of fecal excretion as a decision support tool in response to silent reintroduction of wild-type poliovirus 1 into Israel. J Clin Virol. 2015;66:51-5. doi: 10.1016/j.jcv.2015.03.005.
7. Ben Moshe E. Change in the structure and composition of the Israeli population according to cultural-religion sector in the next twenty years and the implications on the job market. 2011. p. 35.
8. Hird TR, Grassly NC. Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge. PLoS Pathog. 2012;8:e1002599. doi: 10.1371/journal.ppat.1002599.
9. Centers for Disease Control and Prevention (CDC). Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP). 1997. p. 1-25.
10. Kaliner E, Kopel E, Anis E, Mendelson E, Moran-gilad J, et al. The Israeli public health response to wild poliovirus importation. Lancet Infect Dis. 2015, 3099. doi: 10.1016/S1473-3099(15)00064-X.
11. Israeli Central Bureau of Statistics. Municipal profile of Rahat in 2013. 2015. Available: http://www.cbs.gov.il/publications15/local_authorities13_1609/pdf/326_1161.pdf. Accessed 20 March 2016.
12. Israeli Central Bureau of Statistics (2015) Local council profile of Araara in the Negev in 2013. Available: http://www.cbs.gov.il/publications15/local_authorities13_1609/pdf/654_1192.pdf. Accessed 20 March 2016.
13. Moran-Gilad J, Mendelson E, Burns C, Bassal R, Gdalevich M, et al. Field study of faecal excretion as decision support tool in response to silent reintroduction of wild Poliovirus 1 into Israel. 24th European Conference on Clinical Microbiology & Infectious Diseases (ECCMID). Barcelona; 2014.
14. Nathanson N, Kew OM. Special Article From Emergence to Eradication: The Epidemiology of Poliomyelitis Deconstructed. Am J Epidemiol. 2010;172:1213-29. doi: 10.1093/aje/kwq320.
15. Keeling MJ, Rohani P, Pourbohloul B. Modeling Infectious Diseases in Humans and Animals:Modeling Infectious Diseases in Humans and Animals. Clin Infect Dis. 2008;47:864-5.
16. Martinez-bakker M, King AA, Rohani P. Unraveling the Transmission Ecology of Polio. PLoS Biol. 2015;13:1-21. doi: 10.1371/journal.pbio.1002172.
17. Wright PF, Wieland-Alter W, Ilyushina N, Hoen AG, Arita M, et al. Intestinal immunity is a determinant of clearance of poliovirus after oral vaccination. J Infect Dis. 2014;209:1628-34. doi: 10.1093/infdis/jit671.
18. Duintjer Tebbens RJ, Pallansch M, Kew OM, Cáceres VM, Sutter RW, et al. A dynamic model of poliomyelitis outbreaks: learning from the past to help inform the future. Am J Epidemiol. 2005;162:358-72. doi: 10.1093/aje/kwi206.
19. Blake IM, Martin R, Goel A, Khetsuriani N, Everts J, et al. The role of older children and adults in wild poliovirus transmission. Proc Natl Acad Sci U S A. 2014;1:10604-9. doi: 10.1073/pnas.1323688111.
20. Kalkowska DA, Tebbens RJD, Grotto I, Shulman LM, Anis E, et al. Modeling Options to Manage Type 1 Wild Poliovirus Imported Into Israel in 2013. J Infect Dis. 2015;211:1800-12. doi: 10.1093/infdis/jiu674.
21. Fine PEM. M CIA. Transmissibility and Persistence of Oral Polio Vaccine Viruses: Implications for the Global Poliomyelitis Eradication Initiative. Am J Epidemiol. 1999;150:1001-21. doi: 10.1093/aje/kwi188.
22. Neal RM. Slice Sampling. Ann Stat. 2003;31:705-67.
23. Behrend MR, Hu H, Nigmatulina KR, Eckhoff P. A quantitative survey of the literature on poliovirus infection and immunity. Int J Infect Dis. 2014;18:4-13. doi: 10.1016/j.ijid.2013.09.005.
24. Spiegelhalter DJ, Best NG, Carlin BP, van der Linde A. Bayesian measures of model complexity and fit. J R Stat Soc Ser B (Statistical Methodol). 2002;64:583-639.
25. Ghendon YZ, Sanakoyeva II. Comparison of the Resistance of the Intestinal Tract to Poliomyelitis virus (Sabin's Strains) in Persons after Naturally and Experimentally Acquired Immunity. Acta Virol. 1961;5:265-73.
26. Laassri M, Lottenbach K, Belshe R, Wolff M, Rennels M, et al. Effect of Different Vaccination Schedules on Excretion of Oral Poliovirus Vaccine Strains. 20852. 2005.
27. Mangal TD, Aylward RB, Grassly NC. The potential impact of routine immunization with inactivated poliovirus vaccine on wild-type or vaccine-derived poliovirus outbreaks in a posteradication setting. Am J Epidemiol. 2013;178:1579-87. doi: 10.1093/aje/kwt203.
28. Hatch LA, Hughes KE, Pilfold JN. Observations on the excretion of type 1 poliovirus from cases and their contacts. Am J Med Sci. 1958;236:419-24.
29. Gelfand HM, Fox JP, Leblanc DR, Elveback L. Studies on the development of natural immunity to poliomyelitis in Louisiana. V. Passive transfer of polioantibody from mother to fetus, and natural decline and disappearance of antibody in the infant. J Immunol. 1960;85:46-55.
30. Alexander JP, Gary HE, Pallansch MA. Duration of Poliovirus Excretion and Its Implications for Acute Flaccid Paralysis Surveillance: A Review of the Literature. J Infect Dis. 1997;175:24-6.
31. Tulchinsky TH, Ramlawi A, Abdeen Z, Grotto I, Flahault A. Polio lessons 2013: Israel, the West Bank, and Gaza. Lancet. 2013;382:1611-2.
32. World health organization (WHO). Summary of the Response Strategy to Type 2 Poliovirus in the Post OPV2 Cessation Period. 2013.
33. Miller E. The most ambitious vaccine introduction in history. Vaccine. 2014;32:4599-601. doi: 10.1016/j.vaccine.2014.05.057.
34. Bolker BM. Ecological Models and Data in R. New Jersey: Princeton University Press; 2008. p. 16.
35. Paul JR. Epidemiology of poliomyelitis. World Health Orginization monograph series no. 26. Geneva; 1955. p. 9-29.
36. Krugman S, Warren J, Eiger MS, Berman PH, Michaels RM, et al. Immunization with Live Attenuated Poliovirus Vaccine. Am J Dis Child. 1961;101:23-9.
37. Patriarca P, Sutter RW, Oostvogel PM. Outbreaks of paralytic poliomyelitis, 1976-1995. J Infect Dis. 1997;175(Suppl):S165-72.